Skip to main content
Skip to section navigation
Skip to footer
Open menu
About Axogen
About Us
Management Team
Board of Directors
Careers
Organizations We Work With
Grants, Donations and Sponsorships
Ethics and Compliance
Patents
For healthcare professionals
For patients
For investors
Skip to main content
Skip to section navigation
Skip to footer
Overview
News/Events
News / Events Overview
Press Releases
Axogen In the News
IR Calendar
Clinical Conferences
Presentations
Email Alerts
Financial Information
Financial Information Overview
Financial Results
Balance Sheet
Income Statement
Cash Flow
Stock Data
Current Quote
Charts
Historical Data
Analyst Coverage
SEC Filings
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Corporate Governance
Governance Overview
Board of Directors
Board Committees
Governance Documents
Contact the Board
Additional Information
Contacts
FAQ
Axogen In the News
Investors
Investors
Overview
News/Events
News / Events Overview
Press Releases
Axogen In the News
IR Calendar
Clinical Conferences
Presentations
Email Alerts
Financial Information
Financial Information Overview
Financial Results
Balance Sheet
Income Statement
Cash Flow
Stock Data
Current Quote
Charts
Historical Data
Analyst Coverage
SEC Filings
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Corporate Governance
Governance Overview
Board of Directors
Board Committees
Governance Documents
Contact the Board
Additional Information
Contacts
FAQ
Oct 9, 2019
Avance Nerve Graft Technology Provides Improvements in Damaged Motor and Sensory Nerves
Aug 29, 2019
How One Woman Regained Sensation 10 Years After a Double Mastectomy
Aug 1, 2019
New Advancement in Breast Reconstruction Surgery Now Available in New Orleans
Jul 15, 2019
Local nerve graft technology helps Ocala man
Jul 2, 2019
After a near-severed finger, she became a first for Cape Cod
Jun 25, 2019
CEO Corner, with Karen Zaderej (Axogen Corporation, Nasdaq:AXGN)
Jun 7, 2019
Axogen CEO Says Innovation and Culture Gives Company a Hiring Edge
Apr 29, 2019
Developer: Offices by Armature Works reaching target market
Apr 1, 2019
The Watch List: Karen Zaderej on Axogen’s Nerve Damage Research
Jan 15, 2019
AxoGen Announces RECON® Study Update
rss_feed
RSS
Previous Page
arrow_back
Page
1
Page
2
Page
3
Page
4
Page
5
Page
6
Page
7
Page
8
Page
9
Page
10
Page
11
Next Page
arrow_forward
Select a page
Page 1
Page 2
Page 3
Page 4
Page 5
Page 6
Page 7
Page 8
Page 9
Page 10
Page 11
email
Email Alerts
contact_page
Contacts
rss_feed
RSS News Feed
accessibility
Accessibility Statement
